TAU-Medical

Our technology is a state-of-the-art treatment with a simple minimally invasive approach targeting specific areas or blood vessels within the heart valve and ventricular septum.

TAU-Medical

Our technology is a state-of-the-art treatment with a simple minimally invasive approach targeting specific areas or blood vessels within the heart valve and ventricular septum.

TAU-Medical

Our technology is a state-of-the-art treatment with a simple minimally invasive approach targeting specific areas or blood vessels within the heart valve and ventricular septum.

TAU-Medical

Our technology is a state-of-the-art treatment with a simple minimally invasive approach targeting specific areas or blood vessels within the heart valve and ventricular septum.

Pivot-TR

The least invasive procedure for Tricuspid Valve repair:
15-minute, atraumatic anchor, retrievable, no sutures, no clips

LV reshaping Loop

Beyond treating Mitral Valve Regurgitation,
Tau’s innovative device promotes LV reshaping for treatment of failing LV

The health of your heart
matters to Tau-Medical.
That’s why our team always
prioritizes excellence for technology.

Tau-Medical Inc.

We have been researching and developing state-of-the-art minimally invasive surgical methodologies for treating Tricuspid Valve Regurgitation (TR), Mitral Valve Regurgitation (MR), Hypertrophic Obstructive Cardiomyopathy (HOCM), and Heart arrhythmia. Our R&D centers and manufacturing facilities are located in Busan and Yangsan in Korea, and we are actively preparing for global clinical trials with top-tier cardiac clinical experts in the USA and Europe.

© Tau-Medical Inc. All Rights Reserved.